GGrantIndex
← Leaderboards

Machelle T. Pardue

Veterans Health Administration

$7,190,905
Attributed
$9,731,738
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,609,738 · 5
VA$0 · 6

By mechanism

R01$9,248,889 · 3
P30$1,878,000 · 1
T32$482,849 · 1
I01$0 · 4
IK6$0 · 1
IS1$0 · 1

Top collaborators

Most similar at Veterans Health Administration

Same institution · by research overlap

Others in their field

Top investigators on “Vision

Research focus

VisionRetinaVisualPreventResponseSignal TransductionBlindnessExperimental StudyAffectFundingBaseDopamineRetinal DegenerationPathologyMolecularFunctional DisorderPathway InteractionsTissuesDetectionMyopiaGrowthDefectEnvironmentSignal Pathway

Grant awards (59)

P30-Core Grant for Vision Research$626,000
P30 · FY2025 · EY · contact PI
Mechanisms of axial elongation in myopia$559,114
R01 · FY2025 · EY · contact PI
Retinal mechanisms of refractive development$491,512
R01 · FY2025 · EY · contact PI
VIsion Science Training in Atlanta$248,459
T32 · FY2025 · EY · contact PI
RR&D Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Treating early stage diabetic retinopathy$0
I01 · FY2025 · VA · contact PI
P30-Core Grant for Vision Research$626,000
P30 · FY2024 · EY · contact PI
Mechanisms of axial elongation in myopia$562,204
R01 · FY2024 · EY · contact PI
Multidisciplinary Training in Vision and Research$234,390
T32 · FY2024 · EY · contact PI
Treating early stage diabetic retinopathy$0
I01 · FY2024 · VA · contact PI
RR&D Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
P30-Core Grant for Vision Research$626,000
P30 · FY2023 · EY · contact PI
Mechanisms of axial elongation in myopia$590,454
R01 · FY2023 · EY · contact PI
Treating early stage diabetic retinopathy$0
I01 · FY2023 · VA · contact PI
RR&D Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
Ocular Sequelae and Intervention in a Rat Model of Blast Overpressure Polytrauma$0
I01 · FY2023 · VA
Mechanisms of axial elongation in myopia$598,845
R01 · FY2022 · EY
Retinal Mechanisms of Refractive Development$208,012
R01 · FY2022 · EY · contact PI
Retinal Mechanisms of Refractive Development$80,798
R01 · FY2022 · EY · contact PI
Treating early stage diabetic retinopathy$0
I01 · FY2022 · VA · contact PI
RR&D Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
Ocular Sequelae and Intervention in a Rat Model of Blast Overpressure Polytrauma$0
I01 · FY2022 · VA
Exercise-induced Retinal Neuroprotection$483,102
R01 · FY2021 · EY
Retinal Mechanisms of Refractive Development$289,063
R01 · FY2021 · EY · contact PI
RR&D Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
ShEEP Request for Confocal Microscope$0
IS1 · FY2021 · VA · contact PI
Ocular Sequelae and Intervention in a Rat Model of Blast Overpressure Polytrauma$0
I01 · FY2021 · VA
Dopamine treatments for diabetic retinopathy$0
I01 · FY2021 · VA · contact PI
Exercise-induced Retinal Neuroprotection$498,044
R01 · FY2020 · EY
Retinal Mechanisms of Refractive Development$298,253
R01 · FY2020 · EY · contact PI
Retinal Mechanisms of Refractive Development$30,000
R01 · FY2020 · EY · contact PI
Dopamine treatments for diabetic retinopathy$0
I01 · FY2020 · VA · contact PI
RR&D Research Career Scientist Award Application$0
IK6 · FY2020 · VA · contact PI
Ocular Sequelae and Intervention in a Rat Model of Blast Overpressure Polytrauma$0
I01 · FY2020 · VA
Exercise-induced Retinal Neuroprotection$498,044
R01 · FY2019 · EY
Retinal Mechanisms of Refractive Development$304,992
R01 · FY2019 · EY · contact PI
Dopamine treatments for diabetic retinopathy$0
I01 · FY2019 · VA · contact PI
RR&D Research Career Scientist Award Application$0
IK6 · FY2019 · VA · contact PI
Ocular Sequelae and Intervention in a Rat Model of Blast Overpressure Polytrauma$0
I01 · FY2019 · VA
Exercise-induced Retinal Neuroprotection$521,653
R01 · FY2018 · EY
Retinal Mechanisms of Refractive Development$389,750
R01 · FY2018 · EY · contact PI
Dopamine treatments for diabetic retinopathy$0
I01 · FY2018 · VA · contact PI
Retinal Mechanisms of Refractive Development$389,750
R01 · FY2017 · EY · contact PI
Ocular Sequelae and Intervention in a Rat Model of Blast Overpressure Polytrauma$0
I01 · FY2017 · VA
Retinal Mechanisms of Refractive Development$389,750
R01 · FY2016 · EY · contact PI
Detecting Early Stage Diabetic Retinopathy$0
I01 · FY2016 · VA · contact PI
Ocular Sequelae and Intervention in a Rat Model of Blast Overpressure Polytrauma$0
I01 · FY2016 · VA
Retinal Mechanisms of Refractive Development$288,251
R01 · FY2015 · EY · contact PI
Retinal mechanisms of refractive development$32,249
R01 · FY2015 · EY · contact PI
Ocular Sequelae and Intervention in a Rat Model of Blast Overpressure Polytrauma$0
I01 · FY2015 · VA
Detecting Early Stage Diabetic Retinopathy$0
I01 · FY2015 · VA · contact PI
Detecting Early Stage Diabetic Retinopathy$0
I01 · FY2015 · VA · contact PI
Detecting Early Stage Diabetic Retinopathy$0
I01 · FY2015 · VA · contact PI
Retinal Mechanisms of Refractive Development$291,403
R01 · FY2013 · EY · contact PI
Retinal Mechanisms of Refractive Development$306,740
R01 · FY2012 · EY · contact PI
Retinal Mechanisms of Refractive Development$306,740
R01 · FY2011 · EY · contact PI
Retinal Mechanisms of Refractive Development$319,523
R01 · FY2010 · EY · contact PI
Retinal Mechanisms of Refractive Development$322,750
R01 · FY2009 · EY · contact PI
Retinal Mechanisms of Refractive Development$197,893
R01 · FY2009 · EY · contact PI